Zentalis Pharmaceuticals

是其中之一......

• Russell 3000.

Zentalis Pharmaceuticals 是一家在股票代码 ZNTL (US) 下上市的公司。

查看带有其 17 名主要高管的组织结构图

Zentalis Pharmaceuticals 搜索最多的简介

• Kimberly Blackwell, Chief Executive Officer and Director
• Karan Takhar, Director
• Enoch Kariuki, Director

高管在Zentalis Pharmaceuticals变化

• Cam Gallagher 曾任 President and Director, 现升职为 Interim Chief Financial Officer, President and Director  (新闻发布的2024四月14号).
• Melissa Epperly, Chief Financial Officer, 已经离开公司  (新闻发布的2024四月14号).
• Kyle Rasbach已作为Chief Business Officer加入公司  (新闻发布的2024一月26号).

更多的变化在％s

创建提醒
跟踪 Zentalis Pharmaceuticals 的高管变动

Zentalis Pharmaceuticals 拥有 1,859 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。

Popular M&A news in 药店

• LakeShore Biopharma将在May 24, 2024将其名称改为LakeShore Biopharma。 (公布2024五月25号).
• MedMen has filed for bankruptcy protection  (公布2024四月28号).
• AstraZeneca has announced the acquisition of Fusion Pharma  (公布2024三月23号).

药店 行业的其他推荐联系人

• Ferring Pharmaceuticals 企业 Jean-Frédéric Paulsen - Executive Chairman of the Board
• GSK 企业 Emma Walmsley - Chief Executive Officer and Director
• Galenika 企业 Danilo Cicmil - Supervisory Board Member

了解更多有关药店行业的信息 >

Zentalis Pharmaceuticals 的最新新闻稿

• Press Releases | Zentalis Pharmaceuticals
• Zentalis to Participate in Investor Call Focused on Ovarian Cancer with Gynecologic Oncology Key Opinion Leader Joyce F. Liu, M.D., MPH, Hosted by TD Cowen | Zentalis Pharmaceuticals
• Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates | Zentalis Pharmaceuticals
• Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Zentalis Pharmaceuticals
• Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Zentalis Pharmaceuticals
• Zentalis Pharmaceuticals to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference | Zentalis Pharmaceuticals
• Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Zentalis Pharmaceuticals
• Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates | Zentalis Pharmaceuticals
• Zentalis Pharmaceuticals to Participate in the Wedbush PacGrow Healthcare Conference | Zentalis Pharmaceuticals
• Zentalis Pharmaceuticals, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Zentalis Pharmaceuticals
• View more press releases Close

关于 Zentalis Pharmaceuticals 的社交媒体

• Zentalis Pharmaceuticals 在 维基百科、谷歌新闻 和 雅虎财经
• Zentalis Pharmaceuticals 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Kimberly Blackwell

致电Zentalis Pharmaceuticals，电话：+1 212...

查看组织结构图

Register to receive your alert

报告错误